Protective Effect of Safranal against Gentamicin-Induced Nephrotoxicity in Rat

Gentamicin is an important aminoglycoside antibiotic. Howeverits use is limited to serious and life threatening gram negativeinfections, because of its high nephrotoxicity potential in patients.There are reports that safranal, the active ingredient ofsaffron with antioxidant properties, exerts prote...

Full description

Bibliographic Details
Main Authors: Mohammad Taher Boroushaki, Hamid Reza Sadeghnia
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2009-12-01
Series:Iranian Journal of Medical Sciences
Subjects:
Online Access:http://ijms.sums.ac.ir/files/PDFfiles/09-Dr_%20Boroushaki.pdf781976685.pdf
_version_ 1818279891781550080
author Mohammad Taher Boroushaki
Hamid Reza Sadeghnia
author_facet Mohammad Taher Boroushaki
Hamid Reza Sadeghnia
author_sort Mohammad Taher Boroushaki
collection DOAJ
description Gentamicin is an important aminoglycoside antibiotic. Howeverits use is limited to serious and life threatening gram negativeinfections, because of its high nephrotoxicity potential in patients.There are reports that safranal, the active ingredient ofsaffron with antioxidant properties, exerts protective effectagainst ischemic injuries occurred by certain nephrotoxins includinggentamicin. Therefore, in the present study, we examinedthe protective effect of safranal against gentamicin-inducednephrotoxicity in rat. After acclimatization, animals were randomlydivided to three groups (8 rats /each group). On day one,each animal was placed separately in a metabolic cage for collecting24-hour urine samples. On day two, after collectingurine samples for measuring glucose and protein, the rats ingroup 1 received saline 1 ml/kg for 6 days, those in group 2 receivedgentamicin 80 mg/kg/day for 6 days, and the remainingrats in group 3 received safranal 0.5 ml/kg followed by gentamicin80 mg/kg/day for 6 days. Injections were intraperitoneally.All the animals were euthanized 24 hours after the lastdose. Blood samples were collected by cardiac puncture, andconcentration of blood urea, creatinine, and urinary glucose andprotein, as the indicators of nephrotoxicity were measured. Ourresults showed that in group 2, concentration of blood urea nitrogenp<0.01, creatinine p<0.05, urinary glucose p<0.001, andprotein p<0.01 were significantly increased compared with thecontrol and safranal-treated groups. There was no significantdifference between the control and safranal-treated groups.Safranal exerts protective effects against gentamicin-inducednephrotoxicity in rat.
first_indexed 2024-12-12T23:40:32Z
format Article
id doaj.art-a6e2356acfa34d6ea5bda790866482a2
institution Directory Open Access Journal
issn 0253-0716
1735-3688
language English
last_indexed 2024-12-12T23:40:32Z
publishDate 2009-12-01
publisher Shiraz University of Medical Sciences
record_format Article
series Iranian Journal of Medical Sciences
spelling doaj.art-a6e2356acfa34d6ea5bda790866482a22022-12-22T00:07:13ZengShiraz University of Medical SciencesIranian Journal of Medical Sciences0253-07161735-36882009-12-01344285288Protective Effect of Safranal against Gentamicin-Induced Nephrotoxicity in RatMohammad Taher BoroushakiHamid Reza SadeghniaGentamicin is an important aminoglycoside antibiotic. Howeverits use is limited to serious and life threatening gram negativeinfections, because of its high nephrotoxicity potential in patients.There are reports that safranal, the active ingredient ofsaffron with antioxidant properties, exerts protective effectagainst ischemic injuries occurred by certain nephrotoxins includinggentamicin. Therefore, in the present study, we examinedthe protective effect of safranal against gentamicin-inducednephrotoxicity in rat. After acclimatization, animals were randomlydivided to three groups (8 rats /each group). On day one,each animal was placed separately in a metabolic cage for collecting24-hour urine samples. On day two, after collectingurine samples for measuring glucose and protein, the rats ingroup 1 received saline 1 ml/kg for 6 days, those in group 2 receivedgentamicin 80 mg/kg/day for 6 days, and the remainingrats in group 3 received safranal 0.5 ml/kg followed by gentamicin80 mg/kg/day for 6 days. Injections were intraperitoneally.All the animals were euthanized 24 hours after the lastdose. Blood samples were collected by cardiac puncture, andconcentration of blood urea, creatinine, and urinary glucose andprotein, as the indicators of nephrotoxicity were measured. Ourresults showed that in group 2, concentration of blood urea nitrogenp<0.01, creatinine p<0.05, urinary glucose p<0.001, andprotein p<0.01 were significantly increased compared with thecontrol and safranal-treated groups. There was no significantdifference between the control and safranal-treated groups.Safranal exerts protective effects against gentamicin-inducednephrotoxicity in rat.http://ijms.sums.ac.ir/files/PDFfiles/09-Dr_%20Boroushaki.pdf781976685.pdfSafranalgentamicinnephrotoxicity
spellingShingle Mohammad Taher Boroushaki
Hamid Reza Sadeghnia
Protective Effect of Safranal against Gentamicin-Induced Nephrotoxicity in Rat
Iranian Journal of Medical Sciences
Safranal
gentamicin
nephrotoxicity
title Protective Effect of Safranal against Gentamicin-Induced Nephrotoxicity in Rat
title_full Protective Effect of Safranal against Gentamicin-Induced Nephrotoxicity in Rat
title_fullStr Protective Effect of Safranal against Gentamicin-Induced Nephrotoxicity in Rat
title_full_unstemmed Protective Effect of Safranal against Gentamicin-Induced Nephrotoxicity in Rat
title_short Protective Effect of Safranal against Gentamicin-Induced Nephrotoxicity in Rat
title_sort protective effect of safranal against gentamicin induced nephrotoxicity in rat
topic Safranal
gentamicin
nephrotoxicity
url http://ijms.sums.ac.ir/files/PDFfiles/09-Dr_%20Boroushaki.pdf781976685.pdf
work_keys_str_mv AT mohammadtaherboroushaki protectiveeffectofsafranalagainstgentamicininducednephrotoxicityinrat
AT hamidrezasadeghnia protectiveeffectofsafranalagainstgentamicininducednephrotoxicityinrat